Zishan Cui
Overview
Explore the profile of Zishan Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Young S, Fairbairn N, Cui Z, Bach P, Mok W, Budau J, et al.
Addiction
. 2025 Jan;
PMID: 39871812
Aims: We measured the association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy (OAT) for opioid use disorder. Design: Retrospective cohort study using the British Columbia...
2.
Mitra S, Richardson L, Cui Z, Gilbert M, Milloy M, Hayashi K, et al.
Soc Sci Med
. 2025 Jan;
366:117661.
PMID: 39827688
Background: While marked gender-based differences in drug-related risk and harm between men women who use drugs have been characterized to some extent, the complex relationship between gendered socioeconomic conditions, overdose...
3.
Cui Z, Karamouzian M, Law M, Hayashi K, Milloy M, Kerr T
Int J Ment Health Addict
. 2024 Dec;
22(6):4004-4020.
PMID: 39722780
Supplementary Information: The online version contains supplementary material available at 10.1007/s11469-023-01098-8.
4.
Anand R, Penta S, Cui Z, Fairbairn N, Socias M
Subst Use Addctn J
. 2024 Oct;
46(2):384-390.
PMID: 39394672
Canada is currently experiencing a problematic opioid crisis with increasing mortality rates. Traditional randomized controlled trials (RCTs) that examine the effectiveness of pharmacological treatment options for people with opioid use...
5.
Hayashi K, Rabu G, Cui Z, Klaire S, Homayra F, Milloy M, et al.
Subst Use Addctn J
. 2024 May;
45(4):653-663.
PMID: 38804580
Background: For structurally marginalized populations, including people who use drugs (PWUD), equitable access to healthcare can be achieved through healthcare access supports. However, few studies characterized utilization of formal (eg,...
6.
McAdam E, Hayashi K, Cui Z, Anderson H, Nelson S, Milloy M, et al.
Harm Reduct J
. 2024 Apr;
21(1):86.
PMID: 38678228
Background: During the early period of the COVID-19 pandemic, public health orders disrupted income generation in numerous sectors and many governments provided emergency financial support. Access to government support and...
7.
Wood E, Pan J, Cui Z, Bach P, Dennis B, Nolan S, et al.
JAMA
. 2024 Apr;
331(14):1215-1224.
PMID: 38592385
Importance: The accuracy of screening tests for alcohol use disorder (defined as a problematic pattern of alcohol use leading to clinically significant impairment or distress) requires reassessment to align with...
8.
Socias M, Cui Z, Le Foll B, Lei J, Stewart S, Anand R, et al.
HIV Med
. 2024 Mar;
25(7):817-825.
PMID: 38506171
Introduction: People who use drugs are disproportionally affected by sexually transmitted and blood-borne infections (STBBIs). While the benefits of methadone in reducing injecting-risk behaviours are well documented, less is known...
9.
Mitra S, Kerr T, Cui Z, Gilbert M, Fleury M, Hayashi K, et al.
J Urban Health
. 2024 Mar;
101(2):402-425.
PMID: 38472731
Socioeconomic factors are important correlates of drug use behaviors and health-related outcomes in people who use drugs (PWUD) residing in urban areas. However, less is known about the complex overlapping...
10.
Langlois J, Nolan S, Dickhout P, Cui Z, Paterson J, Fairbairn N, et al.
Subst Use Addctn J
. 2024 Jan;
45(2):176-180.
PMID: 38254287
North America is facing an unprecedented public health emergency of opioid-related morbidity and mortality. The mortality benefits of oral medication treatment for opioid use disorder (MOUD), such as methadone or...